INTRODUCTION
Beyond the value as a beverage, green tea possesses medicinal and health-supporting functions such as cytoprotective, antioxidant, antiplatelet, antibacterial, antiallergic, anti-inflammatory, hypolipidemic activity, etc. 1) In particular, increasing attention has been paid to the cancer prevention and therapy by green tea which affects diverse cellular events relating to cancer development. These effects are attributed to polyhydroxyflavan-3-ol or catechin and its derivatives, the constituents in tea leaves (Camellia sinensis), which inhibit proliferation, metastasis and lipid peroxidation of tumor cells. In addition to conventional mechanisms, another mode of action on biomembranes has been implicated in antiproliferative medicines and food components. 2) Cell membranes, as well as membranous organelles, are regarded as one of novel targets for antitumor agents. 3) The lipid environments of biomembranes modulate the activities of enzymes and receptors embedded in them. While many tumor cell lines show different membrane properties, like fluidity changes, from their normal counterparts, 4) the fluidity modification of cellular, mitochondrial and liposomal membranes results in the growth inhibition of tumor cells. 5, 6) Membrane fluidity also affects enzymes and lipid hydroperoxides responsible for carcinogenesis. 7) Green tea catechins consist of stereoisomers and 3-gallate esters. Their structure-activity relationship indicates that (+)-catechin (C), (-)-epicatechin (EC), (-)-epicatechin-3-gallate (ECG) and (-)-epigallocatechin-3-gallate (EGCG) are suitable for the comparative study. They are not only discriminable in antitumor and membrane activity, 8) but also quantitatively the representative constituents in green tea. 9) The purpose of this study was to compare the antiproliferative effects of C, EC, ECG and EGCG with relating to their effects on cell membranes and lipid bilayers to modify the membrane fluidity.
MATERIALS AND METHODS
Materials --C, EC, ECG and EGCG purified from tea leaves were obtained from Kurita (Tokyo, Japan). Their purity was confirmed to be more than 99% by HPLC. 10) Phospholipids: 1-palmitoyl-2-oleoylphosphatidylcholine (POPC), 1-palmitoyl-2-oleoylphosphatidylethanolamine (POPE) and 1-stearoyl-2-oleoylphosphatidylserine (SOPS) were purchased from Avanti Polar Lipids (Alabaster, AL, U.S.A.), and cholesterol from Wako Pure Chemicals (Osaka, Japan). Fluorescent probes: 1-anilinonaphthalene-8-sulfonic acid (ANS), N-phenyl-1-naphthylamine (PNA), 2-(9-anthroyloxy)stearic acid (2-AS), 6-(9-anthroyloxy)stearic acid (6-AS), 9-(9-anthroyloxy)stearic acid (9-AS), 12-(9-anthroyloxy)stearic acid (12-AS) and 16-(9-anthroyloxy)palmitic acid (16-AP) were obtained from Molecular Probes (Eugene, OR, U.S.A.). Dimethyl sulfoxide (DMSO) of spectroscopic grade (Kishida, Osaka, Japan) was used for preparing sample solutions. All other reagents were of the highest grade available commercially. Cell Culture --Mouse myeloma cells (Sp2/OAg14) were maintained in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) fetal calf serum (ICN Biomedicals, Aurora, OH, U.S.A.) at 37 • C in a humidified 5% CO 2 atmosphere. This cell line was used because it was suitable for membrane fluidity experiments, in which the cells were readily suspended in phosphate-buffered saline of pH 7.4 (PBS) and successfully labeled with different probes. Antiproliferative Effect --The antiproliferative effects of catechins were assayed as reported previously. 11) In brief, the cells were inoculated at 3.0 × 10 5 cells/ml in culture medium, to which the DMSO solutions of C, EC, ECG and EGCG were added to be 100 µM for each. The final concentration of DMSO was 0.5% (v/v) in medium. After culture for 24 and 48 hr, the number of viable cells was compared with controls to obtain cell growth inhibition (%). Cell Membrane Fluidity Change --The cells were cultured with or without C, EC, ECG and EGCG (100 µM for each) as described above. An aliquot (2 ml) of cell cultures was collected after culture for 1-48 hr. After centrifugation, the collected cells were washed twice with and suspended in PBS at 5.0 × 10 4 cells/ml. They were labeled with ANS, PNA, 2-AS, 6-AS, 9-AS, 12-AS or 16-AP, and then the fluidity changes of cell membranes were determined by measuring fluorescence polarization as reported previously. 8, 12) Compared with controls (treated with DMSO vehicle), the increases of polarization values mean the reduction of membrane fluidity, membrane rigidification. ANS and PNA indicate the fluidity changes in hydrophilic and hydrophobic upper regions of membranes, respectively. Since n-(9-anthroyloxy) fatty acids (n = 2, 6, 9, 12, 16) selectively locate at a graded series of levels in lipid bilayers, fluorescence polarization reflects the fluidity gradient extending from the surface to the center of membranes with an increase of n. In order to characterize the membrane-acting sites of catechins, their induced changes relative to control polarization values (%) were compared between n-AS(P) polarization. 13) Membrane Lipid Interaction --Liposomal tumor cell model membranes of the lipid bilayer structure were prepared as the suspensions in PBS by the previous method. 14) The membrane lipid composition was POPC, POPE, SOPS and cholesterol (48 : 24 : 8 : 20, mol%; total lipids of 0.14 mM), corresponding to that of tumor cell membranes. 15) The DMSO solutions of C, EC, ECG and EGCG were added to the membrane preparations to give a final concentration of 10 µM for each, followed by incubation at 37 
RESULTS AND DISCUSSION
EGCG and ECG showed antiproliferative effects at 100 µM with the potency being EGCG > ECG, but neither EC nor C. Compared with control cultures, the growth inhibition of tumor cells cultured for 24 and 48 hr was 70.2 ± 1.8% and 85.6 ± 1.0% by EGCG, and 34.8 ± 2.2% and 69.2 ± 1.1% by ECG, respectively. The obtained rank order of antiproliferative activity is the same as that of previous studies, although the tested tumor cells are different. 16, 17) The comparative growthinhibitory effects on various cell lines suggest the possibility for catechins to act on the cell structures common to tumor cells.
Simultaneously with inhibiting the cell growth, EGCG and ECG rigidified tumor cell membranes
Fig. 1. Effects of Catechins on Cell Membranes
Mouse myeloma cells were cultured with catechins (100 µM for each) for 1 and 5 hr. The fluidity changes of cell membranes were determined by measuring fluorescence polarization with ANS and PNA. Mean ± S.E. (n = 5). * p < 0.05 and * * p < 0.01, compared with control.
Fig. 2. Effects of EGCG on Different Regions of Cell Membranes
Mouse myeloma cells were cultured with EGCG (100 µM) for 6-48 hr. The fluidity changes with the gradient extending from the surface to the center of cell membranes were determined by measuring fluorescence polarization with n-AS(P). Mean ± S.E. (n = 5). * * p < 0.01, compared with control.
with the potency being EGCG > ECG by acting on their surfaces and interiors as shown by ANS and PNA polarization increases (Fig. 1) . However, nonantiproliferative EC and C were not or much less effective on tumor cell membranes. The relative potencies to rigidify cell membranes were correlated with those to inhibit cell proliferation, suggesting the relation between antiproliferative and membrane effects of catechins.
For characterizing the cell membrane action, the induced rigidification was compared along graded depths of tumor cell membranes by n-AS(P) polarization increases relative to control values. The most antiproliferative EGCG predominantly affected the hydrophobic cores of cell membranes (Fig. 2) . Not only its acting site was deeper but also its rigidifying potency was greater with increasing the cell culture time, which is interpreted by the time-dependent penetration into cell membranes.
In order to verify the membrane lipid interaction underlying the effects of catechins on tumor cells, tumor cell model membranes consisting of phospholipids and cholesterol were treated with C, EC, ECG and EGCG. EGCG most intensively rigidified the liposomal membranes at 10 µM, followed by ECG, EC and C in decreasing order of intensity as shown by n-AS(P) polarization increases relative to control values (Fig. 3) . This rank order agrees with that found in both potencies to rigidify tumor cell membranes and to inhibit the growth of tumor cells. Liposomes and cell membranes also showed the same features (to act on deeper regions) for the membrane effects of catechins. The interactions of catechins with lipid bilayers are responsible for their induced rigidification of tumor cell membranes. The relative polarization increases by EGCG were smaller in cell membranes than in liposomal membranes. Such difference may be due to the binding of EGCG to medium components and membrane proteins during cell culture. The hydrophobic interaction is related to the membrane effects of catechins. Relative hydrophobicity is estimated to be ECG > EGCG > EC > C based on the reversed-phase chromatographic retention 10) and the partition in n-octanol/PBS system. 18) This rank order suggests the ability of ECG to interact with membrane lipids more intensively than EGCG. ECG was previously reported to be more potent to act on liposomal membranes than EGCG. 8, 19) In this study, however, the relative membrane activity was reversed between ECG and EGCG. This discrepancy is attributable to the compositional difference of membrane lipids, that is, previous liposomes were prepared with phosphatidylcholine alone, whereas the present ones with different unsaturated phospholipids and cholesterol to resemble tumor cell membranes. Tumor cells change their membrane fluidity by decreasing the cholesterol content and increasing the phospholipids unsaturation degree to elevate proliferative and metastatic activities. 4) With respect to the role of cholesterol, it is also of interest that EGCG shows the significant bioactivity by selectively interacting with membrane lipid rafts, 20) in which cholesterol is concentrated to determine the organization, stability and function of membrane microdomains.
Membrane dynamics are so important for cell proliferation that cell cycling is accompanied by membrane fluidity changes and proliferating cells have more fluid membranes than the cells in resting stage. 2) The fluidity enhancement of cell membranes and liposomes is counteracted by antitumor drugs. 5, 6) Membrane-rigidifying catechins inhibit ornithine decarboxylase and cyclooxygenase relevant to cell proliferation and carcinogenesis, 21, 22) and membrane fluidity-modifiers regulate carcinogen-metabolizing and -activating enzyme activities. 7) Fluidity changes also decrease the biochemical reaction efficiency in membrane lipid environments. 3) The membrane rigidification by catechins would not only affect cell events relating to proliferation but also depress lipid peroxidation by hindering the diffusion of free radicals in lipid bilayers. 5, 13) In conclusion, the antiproliferative effects of green tea catechins are associated with their interactivities with lipid bilayers to modify cell membrane fluidity, which depend on the structure of catechins and the composition of membrane lipids.
